Novel imaging technique captures COVID-19’s impact on the brain
A form of MRI is a better alternative to many existing imaging technologies when looking at how COVID-19 can change the human brain.
List view / Grid view
A form of MRI is a better alternative to many existing imaging technologies when looking at how COVID-19 can change the human brain.
Novel 3D bioprinting process could save thousands of lives by streamlining the creation of tissue-compatible artificially engineered organs.
New imaging approach reveals that changes in retinal microcirculation may indicate cerebrovascular diseases that involve reduced blood flow.
Penn Medicine researchers are interested in how cardiac cells use DNA to establish and maintain their specification.
Researchers from Australia explore how viruses can alter brain cells, and thus the functions of our nervous system, leading to neurological symptoms.
Japanese researchers now reveal a new way of activating GPCR by triggering shape changes in the intracellular region of the receptor. This new process can help researchers design drugs with fewer or no side effects.
A study out of Austria suggests gene changes in those with biliary tract cancer offers new avenues for new precision oncology therapies.
US study identifies promising new target, in protein remnants from an ancient virus, for treating underlying cause of ALS.
Fresh insights from University of Edinburgh into a protein that causes damage in kidneys and hearts could open up new treatment options for chronic kidney disease.
US researchers uncover that certain nerve cells that have the capacity to regrow, are necessary for axon regeneration, providing hope for conditions like blindness and paralysis.
US researchers use genome sequencing to reveal genetic basis for disabling pansclerotic morphea, a severe inflammatory disease.
Researchers from South Korea uncover that neurons in the hippocampus play a crucial role in assigning positive value through interactions with others.
Chinese researchers discover a mutation, referred to as the "Shanghai APP" mutation, which has been linked to late-onset Alzheimer's disease and offers fresh insights into the disease's underlying molecular mechanisms.
German researchers have successfully developed mice with a defected human gene responsible for congenital adrenal hyperplasia (CAH), a rare genetic disease.
US study uncovers the best way to treat recurrent or progressive brain metastases using an amino acid PET technique.